Clinical Trial Update: A Study About Fazirsiran in People With and Without Liver Problems [Phase 1]

View source ↗

Summary

Takeda's Phase 1 trial of Fazirsiran in people with and without hepatic impairment has completed, evaluating safety in individuals with varying liver function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• Fazirsiran (fazirsiran)

Snippet

Sponsor: Takeda | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED